期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

小干扰RNA非病毒载体研究进展 被引量：1

The Research of Non-viral Small Interfering RNA Delivery Carriers
下载PDF
导出
摘要 作为一种新的基因治疗方法,小干扰RNA(small interfering RNA,siRNA)载体技术的发展,对许多疾病的临床治疗起着至关重要的作用。本文根据近年来国内外文献报道,将siRNA非病毒纳米载体研究进展进行了综述,并分析了现阶段存在的问题,展望了今后的发展方向。 As a new genic therapy method, development of small interfering RNA （siRNA） delivery vehicles is very important for clinical treatment of many diseases. According to the domestic and abroad literatures in recent years, studies of non-viral nanoparticle of siRNA were reviewed. At the same time, the issues existing in present stage and future development were discussed.
作者 龚建勇
机构地区 海军上海保障基地医院药剂科
出处 《药品评价》 CAS 2013年第24期6-9,19,共5页 Drug Evaluation
关键词 纳米粒 非病毒递送载体 研究进展 siRNA siRNA Nanoparticles Non-viral Delivery Carriers Research Progress
分类号 R450 [医药卫生—治疗学]
  • 相关文献

参考文献34

  • 1Elbashirs M, Lendeckel W, Tuschl T. RNA interference is mediated by 21 -and 22-nucleotide RNAs[J]. Genes Deli. 2001, 15(2): 188-200.
  • 2Lares MR, Rossi JJ, Ouellet DL. RNAi and small interfering RNAs in human disease therapeutic applications[J]. Trends Biotechnol. 2010, 28(11): 570-579.
  • 3Lee SJ, Yhee JY, Kim SH, et hi. Biocompatible gelatin nanoparticles for tumor-targeted delivery of polymerized siRNA in tumor-bearingmice[J]. J Controlled Rel. 2013, 172(1): 358-366.
  • 4Whitehead KA, Langer R, Anderson DG. Knocking down barriers: advances in siRNA delivery[J]. Nat Rev Drug Discov. 2009, 8(2): 129-138.
  • 5Gao S, Dagnaes-Hansen F, Nielsen EJ, eta/. The effect of chemical modification and nanoparticle formulation on stability and biodistribution of siRNA in mice[J]. Mol Ther. 2009, 17(7): 1225-1233.
  • 6Grimm D, Streetz KL, Jopling CL, et al. Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways[J]. Nature. 2006, 441(7092): 537-541.
  • 7Hammond SM, Bernstein E, Beach D, et al. An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells[J]. Nature. 2000, 404(6775): 293-296.
  • 8Zamore PD, Haley B. Ribo-gnome, the big world of small RNAs[J]. Science. 2005, 309(5740): 151%1524.
  • 9Tseng YC, Mozumdar S, Huang L. Lipid-based systemic delivery of siRNA[J]. Adv Drug Deliv Rev. 2009, 61 (9): 721-731.
  • 10Xie FY, Woodlem C, Lu PY. Harnessing in vivo siRNA delivery for drug discovery and therapeutic development[J]. Drug Discov Today. 2006, 11(2): 67-73.

二级参考文献29

  • 1付洁,宋海峰,钱小红.siRNA作为基因治疗药物的研究难题[J].中国新药杂志,2007,16(7):506-510. 被引量：1
  • 2ELBASHIR SM, LENDECKEL W, TUSCHL T. RNA interference is mediated by 21-and 22-nucleotide RNAs[J].Genes Deli, 2001,15(2) : 188 -200.
  • 3ELBASHIR SM, HARBORTH J, LENDECKEL W, et al. Duplexes of 21-nucleotide RNAs mediate RNA interfernce in cultured mammalian cells[J]. Nature, 2001, 411 ( 6836 ) : 494 - 498.
  • 4KALLURI R, KANASAKI K. RNA interference: generic block on angiogenesis[J]. Nature, 2008, 452(7187): 543 -545.
  • 5OKUMURA A, PITHA P, HARTY RN. RNISG15 inhibits Ebola VP40 VLP budding in an L-domain-dependent manner by blocking Nedd4 ligase activity [ J ]. Proc Natl Acad Sci USA, 2008, 105(10) : 3974 -3979.
  • 6CHEN Y, CHENG GF, MAHOTO RI. RNAi for treating hepatitis B viral infection [ J ]. Pharm Res, 2008, 25 (1) :72 -86.
  • 7KIM SH, JEONG JH, LEE SH, et al. Local and systemic delivery of VEGF siRNA using polyelectrolyte complex micelles for effective treatment of cancer [J]. J Control Release, 2008, 129 (2): 107-116.
  • 8XIE FY, WOODLE MC, LU PY. Harnessing in vivo siRNA delivery for drug discovery and therapeutic development[ J]. Drug Discov Today, 2006, 11(2): 67 -73.
  • 9HORNUNG V, GUENTHNER-BILLER M, BOURQUIN C. Sequence-specific potent induction of IFN-α by short interfering RNA in plasmacytoid dendritic cells through TLR7 [ J ]. Nat Med, 2005, 11(3): 263-270.
  • 10JUDGE AD, SOOD V, SHAW JR. Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA [ J ]. Nat Biotechnol, 2005, 23 (4) : 457 - 462.

共引文献4

同被引文献33

  • 1GINN S L,ALEXANDER I E,EDELSTEIN M L,et al.Gene therapy clinical trials worldwide to 2012:an update[J].J Gene Med,2013,15(2):65-77.
  • 2JIN L,ZENG X,LIU M,et al.Current progress in gene delivery technology based on chemical methods and nano-carriers[J].Theranostics,2014,4(3):240-255.
  • 3THOMAS C E,EHRHARDT A,KAY M A.Progress and problems with the use of viral vectors for gene therapy[J].Nat Rev Genet,2003,4(5):346-358.
  • 4SHCHARBIN D,SHAKHBAZAU A,BRYSZEWSKA M.Poly(amidoamine)dendrimer complexes as a platform for gene delivery[J].Exp Opin Drug Deliv,2013,10(12):1687-1698.
  • 5ASSESSMENT OF ADENOVIRAL VECTOR SAFETY ANG TOXICITY.Report of the national institutes of health recombinant DNA advisory committee[J].Hum Gene Ther,2002,13(1):3-13.
  • 6MORRAL N,O'NEAL W K,RICE K,et al.Lethal toxicity,severe endothelial injury,and a threshold effect with high doses of an adenoviral vector in baboons[J].Hum Gene Ther,2002,13(1):143-154.
  • 7THOMAS C E,EHRHARDT A,KAY M A.Progress and problems with the use of viral vectors for gene therapy[J].Nat Rev Genet,2003,4(5):346-358.
  • 8YIN H,KANASTY R L,ELTOUKHY A A,et al.Non-viral vectors for gene-based therapy[J].Nat Rev Genet,2014,15(8):541-555.
  • 9WANG T,UPPONI J R,TORCHILIN V P.Design of multifunctional non-viral gene vectors to overcome physiological barriers:dilemmas and strategies[J].Int J Pharm,2012,427(1):3-20.
  • 10PEZZOLI D,KAJASTE-RUDNITSKI A,CHIESA R,et al.Lipidbased nanoparticles as nonviral gene delivery vectors[J].Methods Mol Biol,2013,1025:269-279.

引证文献1

二级引证文献3

药品评价
2013年 第24期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部